Some investors asked Nanmo Biology, the director, and synthetic biology top-level design documents are about to be released. What is the company's layout in the field of synthetic biology? Are there collaborations with companies in the synthetic biology sector? Nanmo Biotech said on the interactive platform that Nanmo Biotech is mainly engaged in the R&D, production, sales and related technical services of genetically modified animal models, that is, using model organisms such as mice, rats, zebrafish, nematodes, etc. as carriers to import or delete target DNA fragments and modify endogenous genes, and construct biological models that can simulate specific human physiology, pathology, and cellular characteristics. The genetically modified animal models produced by the company mainly refer to genetically modified mouse models. Synthetic biology (synthetic biology) is a branch of biological science that has just emerged in the 21st century. Research on synthetic biological substances has progressed rapidly in recent years. The company provides genetically modified animal models or pharmacodynamics services for drug development companies and CXO companies to assist related companies in pre-clinical research. The company itself is not involved in research in the field of synthetic biology.